Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Dermata Therapeutics, Inc. (DRMA) had Return on Equity of -787.10% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-12.29M |
|
-- |
|
-- |
|
$12.51M |
|
$-12.51M |
|
$0.23M |
|
$-12.29M |
|
$-12.29M |
|
$-12.29M |
|
$-12.29M |
|
$-12.29M |
|
$-12.29M |
|
$-12.51M |
|
$-12.51M |
|
1.53M |
|
1.53M |
|
$-8.03 |
|
$-8.03 |
|
| Balance Sheet Financials | |
$3.53M |
|
-- |
|
-- |
|
$3.53M |
|
$1.97M |
|
-- |
|
-- |
|
$1.97M |
|
$1.56M |
|
$1.56M |
|
$1.56M |
|
2.52M |
|
| Cash Flow Statement Financials | |
$-11.16M |
|
-- |
|
$6.89M |
|
$7.44M |
|
$3.16M |
|
$-4.28M |
|
$0.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-787.10% |
-787.11% |
|
-347.70% |
|
-787.11% |
|
$0.62 |
|
$-7.30 |
|
$-7.30 |
|